BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33548158)

  • 1. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
    Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
    FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mavacamten decreases maximal force and Ca
    Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of 1-43 amino acids in cardiac myosin essential light chain blunts length dependency of Ca(2+) sensitivity and cross-bridge detachment kinetics.
    Michael JJ; Gollapudi SK; Ford SJ; Kazmierczak K; Szczesna-Cordary D; Chandra M
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H253-9. PubMed ID: 23144314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac contractility, motor function, and cross-bridge kinetics in N47K-RLC mutant mice.
    Wang L; Kazmierczak K; Yuan CC; Yadav S; Kawai M; Szczesna-Cordary D
    FEBS J; 2017 Jun; 284(12):1897-1913. PubMed ID: 28467684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.
    Kazmierczak K; Paulino EC; Huang W; Muthu P; Liang J; Yuan CC; Rojas AI; Hare JM; Szczesna-Cordary D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H575-89. PubMed ID: 23748425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
    Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
    FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a myosin regulatory light chain mutation K104E on actin-myosin interactions.
    Duggal D; Nagwekar J; Rich R; Huang W; Midde K; Fudala R; Das H; Gryczynski I; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1248-57. PubMed ID: 25770245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myosin Rod Hypophosphorylation and CB Kinetics in Papillary Muscles from a TnC-A8V KI Mouse Model.
    Kawai M; Johnston JR; Karam T; Wang L; Singh RK; Pinto JR
    Biophys J; 2017 Apr; 112(8):1726-1736. PubMed ID: 28445763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional impact of troponin C-mediated Ca
    Gonzalez-Martinez D; Johnston JR; Landim-Vieira M; Ma W; Antipova O; Awan O; Irving TC; Bryant Chase P; Pinto JR
    J Mol Cell Cardiol; 2018 Oct; 123():26-37. PubMed ID: 30138628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizations of myosin essential light chain's N-terminal truncation mutant Δ43 in transgenic mouse papillary muscles by using tension transients in response to sinusoidal length alterations.
    Wang L; Muthu P; Szczesna-Cordary D; Kawai M
    J Muscle Res Cell Motil; 2013 May; 34(2):93-105. PubMed ID: 23397074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.
    Kampourakis T; Ponnam S; Irving M
    J Mol Cell Cardiol; 2018 Apr; 117():72-81. PubMed ID: 29452157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
    Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
    J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of apical hypertrophic cardiomyopathy with age in a transgenic mouse model carrying the cardiac actin E99K mutation.
    Wang L; Bai F; Zhang Q; Song W; Messer A; Kawai M
    J Muscle Res Cell Motil; 2017 Dec; 38(5-6):421-435. PubMed ID: 29582353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity and similarity of motor function and cross-bridge kinetics in papillary muscles of transgenic mice carrying myosin regulatory light chain mutations D166V and R58Q.
    Wang L; Muthu P; Szczesna-Cordary D; Kawai M
    J Mol Cell Cardiol; 2013 Sep; 62():153-63. PubMed ID: 23727233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.